 WEST LAFAYETTE, Ind., April 30, 2021 GLOBE NEWSWIRE -- Inotiv, Inc. NASDAQ:NOTV the Company, We, Our or Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today announced that the Company has secured 28.0 million in debt financing from First Internet Bank of Indiana and completed the previously-announced acquisition of substantially all of the assets of HistoTox Labs, Inc. HistoTox Labs and the acquisition by merger of Bolder BioPATH, Inc. Bolder BioPATH, effective April 30, 2021. 